1. Home
  2. GKOS vs HWC Comparison

GKOS vs HWC Comparison

Compare GKOS & HWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • HWC
  • Stock Information
  • Founded
  • GKOS 1998
  • HWC 1883
  • Country
  • GKOS United States
  • HWC United States
  • Employees
  • GKOS N/A
  • HWC N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • HWC Major Banks
  • Sector
  • GKOS Health Care
  • HWC Finance
  • Exchange
  • GKOS Nasdaq
  • HWC Nasdaq
  • Market Cap
  • GKOS 5.4B
  • HWC 5.3B
  • IPO Year
  • GKOS 2015
  • HWC N/A
  • Fundamental
  • Price
  • GKOS $84.11
  • HWC $63.09
  • Analyst Decision
  • GKOS Strong Buy
  • HWC Strong Buy
  • Analyst Count
  • GKOS 13
  • HWC 6
  • Target Price
  • GKOS $121.46
  • HWC $69.83
  • AVG Volume (30 Days)
  • GKOS 864.7K
  • HWC 899.2K
  • Earning Date
  • GKOS 11-03-2025
  • HWC 10-14-2025
  • Dividend Yield
  • GKOS N/A
  • HWC 2.84%
  • EPS Growth
  • GKOS N/A
  • HWC 27.47
  • EPS
  • GKOS N/A
  • HWC 5.42
  • Revenue
  • GKOS $432,953,000.00
  • HWC $1,411,463,000.00
  • Revenue This Year
  • GKOS $28.90
  • HWC $11.48
  • Revenue Next Year
  • GKOS $25.57
  • HWC $5.56
  • P/E Ratio
  • GKOS N/A
  • HWC $11.69
  • Revenue Growth
  • GKOS 26.70
  • HWC 8.24
  • 52 Week Low
  • GKOS $77.10
  • HWC $43.90
  • 52 Week High
  • GKOS $163.71
  • HWC $64.66
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 45.81
  • HWC 54.44
  • Support Level
  • GKOS $79.02
  • HWC $60.27
  • Resistance Level
  • GKOS $89.29
  • HWC $64.34
  • Average True Range (ATR)
  • GKOS 3.19
  • HWC 1.25
  • MACD
  • GKOS 0.54
  • HWC -0.13
  • Stochastic Oscillator
  • GKOS 49.76
  • HWC 65.81

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About HWC Hancock Whitney Corporation

Hancock Whitney Corp operates bank offices and financial centers. The company offers a range of traditional and online banking services to commercial, small business, and retail customers, providing a variety of transaction and savings deposit products, treasury management services, secured and unsecured loan products (including revolving credit facilities), letters of credit, and similar financial guarantees. The Bank provides trust and investment management services to retirement plans, corporations, and individuals and provides its customers access to investment advisory and brokerage products.

Share on Social Networks: